Form 8-K - Current report:
SEC Accession No. 0001104659-25-125026
Filing Date
2025-12-30
Accepted
2025-12-30 08:05:50
Documents
14
Period of Report
2025-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2534421d1_8k.htm   iXBRL 8-K 27846
2 EXHIBIT 99.1 tm2534421d1_ex99-1.htm EX-99.1 13225
6 GRAPHIC tm2534421d1_ex99-1img01.jpg GRAPHIC 17262
  Complete submission text file 0001104659-25-125026.txt   236382

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA coll-20251223.xsd EX-101.SCH 3035
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20251223_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20251223_pre.xml EX-101.PRE 22372
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2534421d1_8k_htm.xml XML 3228
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 251611085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)